دورية أكاديمية

Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through 'reverse phenotyping'.

التفاصيل البيبلوغرافية
العنوان: Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through 'reverse phenotyping'.
المؤلفون: Fischer DS; Institute of Computational Biology, Helmholtz Zentrum München, Neuherberg, München, Germany.; TUM School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany., Ansari M; Institute of Computational Biology, Helmholtz Zentrum München, Neuherberg, München, Germany.; Institute of Lung Biology and Disease and Comprehensive Pneumology Center with the CPC-M bioArchive, Helmholtz Zentrum Muenchen, Member of the German Center for Lung Research (DZL), Munich, Germany., Wagner KI; Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München (TUM), Munich, Germany., Jarosch S; Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München (TUM), Munich, Germany., Huang Y; Institute of Virology, Technische Universität München (TUM), Munich, Germany., Mayr CH; Institute of Lung Biology and Disease and Comprehensive Pneumology Center with the CPC-M bioArchive, Helmholtz Zentrum Muenchen, Member of the German Center for Lung Research (DZL), Munich, Germany., Strunz M; Institute of Lung Biology and Disease and Comprehensive Pneumology Center with the CPC-M bioArchive, Helmholtz Zentrum Muenchen, Member of the German Center for Lung Research (DZL), Munich, Germany., Lang NJ; Institute of Lung Biology and Disease and Comprehensive Pneumology Center with the CPC-M bioArchive, Helmholtz Zentrum Muenchen, Member of the German Center for Lung Research (DZL), Munich, Germany., D'Ippolito E; Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München (TUM), Munich, Germany., Hammel M; Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München (TUM), Munich, Germany., Mateyka L; Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München (TUM), Munich, Germany., Weber S; Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München (TUM), Munich, Germany., Wolff LS; Institute of Virology, Technische Universität München (TUM), Munich, Germany., Witter K; Laboratory of Immunogenetics and Molecular Diagnostics, Department of Transfusion Medicine, Cell Therapeutic Agents and Hemostaseology, LMU Munich, Munich, Germany.; Department of Medicine V, University Hospital, LMU Munich, Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for lung research (DZL), Munich, Germany., Fernandez IE; Department of Medicine V, University Hospital, LMU Munich, Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for lung research (DZL), Munich, Germany., Leuschner G; Department of Medicine V, University Hospital, LMU Munich, Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for lung research (DZL), Munich, Germany., Milger K; Department of Medicine V, University Hospital, LMU Munich, Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for lung research (DZL), Munich, Germany., Frankenberger M; Institute of Lung Biology and Disease and Comprehensive Pneumology Center with the CPC-M bioArchive, Helmholtz Zentrum Muenchen, Member of the German Center for Lung Research (DZL), Munich, Germany.; Center for Thoracic Surgery Munich, Ludwig-Maximilians-University of Munich (LMU) and Asklepios Lung Clinic Munich-Gauting, Munich and Gauting, Munich, Germany., Nowak L; Center for Thoracic Surgery Munich, Ludwig-Maximilians-University of Munich (LMU) and Asklepios Lung Clinic Munich-Gauting, Munich and Gauting, Munich, Germany., Heinig-Menhard K; Center for Thoracic Surgery Munich, Ludwig-Maximilians-University of Munich (LMU) and Asklepios Lung Clinic Munich-Gauting, Munich and Gauting, Munich, Germany., Koch I; Institute of Lung Biology and Disease and Comprehensive Pneumology Center with the CPC-M bioArchive, Helmholtz Zentrum Muenchen, Member of the German Center for Lung Research (DZL), Munich, Germany.; Asklepios Biobank for pulmonary diseases, Gauting, Germany.; Member of the German Center for Lung Research (DZL), Center for Comprehensive Developmental Care (CDeCLMU), Department of Neonatology, Perinatal Center, Munich, Germany., Stoleriu MG; Institute of Lung Biology and Disease and Comprehensive Pneumology Center with the CPC-M bioArchive, Helmholtz Zentrum Muenchen, Member of the German Center for Lung Research (DZL), Munich, Germany.; Asklepios Biobank for pulmonary diseases, Gauting, Germany.; Member of the German Center for Lung Research (DZL), Center for Comprehensive Developmental Care (CDeCLMU), Department of Neonatology, Perinatal Center, Munich, Germany., Hilgendorff A; Institute of Lung Biology and Disease and Comprehensive Pneumology Center with the CPC-M bioArchive, Helmholtz Zentrum Muenchen, Member of the German Center for Lung Research (DZL), Munich, Germany.; German Center for Infection Research (DZIF), partner site Munich, Munich, Germany., Behr J; Department of Medicine V, University Hospital, LMU Munich, Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for lung research (DZL), Munich, Germany.; Center for Thoracic Surgery Munich, Ludwig-Maximilians-University of Munich (LMU) and Asklepios Lung Clinic Munich-Gauting, Munich and Gauting, Munich, Germany., Pichlmair A; Institute of Virology, Technische Universität München (TUM), Munich, Germany.; Department of Mathematics, Technical University of Munich, Garching, Germany., Schubert B; Institute of Computational Biology, Helmholtz Zentrum München, Neuherberg, München, Germany.; Focus Group 'Clinical Cell Processing and Purification', Institute for Advanced Study, TUM, Munich, Germany., Theis FJ; Institute of Computational Biology, Helmholtz Zentrum München, Neuherberg, München, Germany.; Focus Group 'Clinical Cell Processing and Purification', Institute for Advanced Study, TUM, Munich, Germany., Busch DH; Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München (TUM), Munich, Germany.; Department of Mathematics, Technical University of Munich, Garching, Germany.; Grosshadern, Hospital of the Ludwig-Maximilians University (LMU), Munich, Germany., Schiller HB; Institute of Lung Biology and Disease and Comprehensive Pneumology Center with the CPC-M bioArchive, Helmholtz Zentrum Muenchen, Member of the German Center for Lung Research (DZL), Munich, Germany. herbert.schiller@helmholtz-muenchen.de.; Institute of Lung Biology and Disease, Comprehensive Pneumology Center, Helmholtz Zentrum München, Neuherberg, München, Germany. herbert.schiller@helmholtz-muenchen.de., Schober K; Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München (TUM), Munich, Germany. kilian.schober@uk-erlangen.de.; Microbiological Institute-Institute of Clinical Microbiology, Immunology and Hygiene, University Hospital of Erlangen, Erlangen, Germany. kilian.schober@uk-erlangen.de.
المصدر: Nature communications [Nat Commun] 2021 Jul 26; Vol. 12 (1), pp. 4515. Date of Electronic Publication: 2021 Jul 26.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
أسماء مطبوعة: Original Publication: [London] : Nature Pub. Group
مواضيع طبية MeSH: COVID-19/*immunology , Gene Expression Profiling/*methods , Sequence Analysis, RNA/*methods , Single-Cell Analysis/*methods , T-Lymphocytes/*metabolism, Aged ; Aged, 80 and over ; CD4-Positive T-Lymphocytes/metabolism ; CD4-Positive T-Lymphocytes/virology ; COVID-19/epidemiology ; COVID-19/virology ; Cells, Cultured ; Cohort Studies ; Female ; Humans ; Male ; Middle Aged ; Pandemics ; Receptors, Antigen, T-Cell/genetics ; Receptors, Antigen, T-Cell/immunology ; Receptors, Antigen, T-Cell/metabolism ; SARS-CoV-2/physiology ; T-Lymphocytes/virology
مستخلص: The in vivo phenotypic profile of T cells reactive to severe acute respiratory syndrome (SARS)-CoV-2 antigens remains poorly understood. Conventional methods to detect antigen-reactive T cells require in vitro antigenic re-stimulation or highly individualized peptide-human leukocyte antigen (pHLA) multimers. Here, we use single-cell RNA sequencing to identify and profile SARS-CoV-2-reactive T cells from Coronavirus Disease 2019 (COVID-19) patients. To do so, we induce transcriptional shifts by antigenic stimulation in vitro and take advantage of natural T cell receptor (TCR) sequences of clonally expanded T cells as barcodes for 'reverse phenotyping'. This allows identification of SARS-CoV-2-reactive TCRs and reveals phenotypic effects introduced by antigen-specific stimulation. We characterize transcriptional signatures of currently and previously activated SARS-CoV-2-reactive T cells, and show correspondence with phenotypes of T cells from the respiratory tract of patients with severe disease in the presence or absence of virus in independent cohorts. Reverse phenotyping is a powerful tool to provide an integrated insight into cellular states of SARS-CoV-2-reactive T cells across tissues and activation states.
(© 2021. The Author(s).)
References: Immunity. 2019 Jan 15;50(1):91-105.e4. (PMID: 30638736)
Nature. 2020 Aug;584(7821):457-462. (PMID: 32668444)
Nat Biomed Eng. 2019 Dec;3(12):974-984. (PMID: 31182835)
Nat Med. 2021 Jan;27(1):78-85. (PMID: 33184509)
Immunity. 2008 Jul 18;29(1):33-43. (PMID: 18619870)
J Immunol. 2013 Apr 15;190(8):3967-76. (PMID: 23479226)
Nat Med. 2019 Sep;25(9):1428-1441. (PMID: 31501614)
Nat Med. 2005 Oct;11(10):1118-24. (PMID: 16186818)
Immunity. 2020 Nov 17;53(5):1095-1107.e3. (PMID: 33128877)
Immunol Cell Biol. 2016 Jul;94(6):604-11. (PMID: 26860370)
Cell Rep. 2017 Sep 19;20(12):2921-2934. (PMID: 28930685)
Nat Immunol. 2020 Apr;21(4):434-441. (PMID: 32205883)
Nat Med. 2020 Apr;26(4):453-455. (PMID: 32284614)
Elife. 2020 Feb 05;9:. (PMID: 32022686)
Cell. 2020 Oct 1;183(1):158-168.e14. (PMID: 32979941)
Eur J Immunol. 2019 Jan;49(1):96-111. (PMID: 30431161)
Nat Methods. 2016 Apr;13(4):329-332. (PMID: 26950746)
Sci Immunol. 2020 Nov 18;5(53):. (PMID: 33208380)
Nat Med. 2020 Jun;26(6):842-844. (PMID: 32398875)
Nat Immunol. 2013 Jul;14(7):741-8. (PMID: 23685786)
Cell. 2020 Jun 25;181(7):1489-1501.e15. (PMID: 32473127)
N Engl J Med. 2020 Apr 30;382(18):1708-1720. (PMID: 32109013)
Nature. 1999 Oct 14;401(6754):708-12. (PMID: 10537110)
Nat Methods. 2020 Feb;17(2):159-162. (PMID: 31819264)
Nat Immunol. 2021 Jan;22(1):74-85. (PMID: 32999467)
Cell. 2020 Nov 12;183(4):996-1012.e19. (PMID: 33010815)
Trends Immunol. 2007 Feb;28(2):66-73. (PMID: 17197236)
Genome Biol. 2018 Feb 6;19(1):15. (PMID: 29409532)
Bioinformatics. 2020 Sep 15;36(18):4817-4818. (PMID: 32614448)
Cell. 2020 Nov 25;183(5):1340-1353.e16. (PMID: 33096020)
Sci Immunol. 2020 Jun 26;5(48):. (PMID: 32591408)
Nat Commun. 2019 Oct 17;10(1):4706. (PMID: 31624246)
Nat Rev Immunol. 2020 Sep;20(9):529-536. (PMID: 32728222)
Gigascience. 2020 Dec 26;9(12):. (PMID: 33367645)
J Immunol. 2001 Apr 15;166(8):4870-8. (PMID: 11290763)
Sci Rep. 2017 Jan 16;7:40253. (PMID: 28091516)
J Immunol. 2011 Jul 1;187(1):7-9. (PMID: 21690331)
Nature. 2006 Apr 13;440(7086):890-5. (PMID: 16612374)
Cancer Res. 2006 Sep 1;66(17):8878-86. (PMID: 16951205)
Immunity. 2007 Oct;27(4):670-84. (PMID: 17950003)
Immunity. 2019 Feb 19;50(2):493-504.e7. (PMID: 30737144)
Cell Rep. 2021 May 25;35(8):109174. (PMID: 34038736)
Immunity. 2020 Dec 15;53(6):1258-1271.e5. (PMID: 33296686)
Nat Biotechnol. 2018 Dec 03;:. (PMID: 30531897)
Nature. 2020 Nov;587(7833):270-274. (PMID: 32726801)
Front Immunol. 2019 Nov 06;10:2568. (PMID: 31781096)
Eur J Immunol. 2019 Jan;49(1):79-95. (PMID: 30144030)
F1000Res. 2016 Aug 31;5:2122. (PMID: 27909575)
Nat Methods. 2016 Oct;13(10):845-8. (PMID: 27571553)
Cell. 2013 Jun 6;153(6):1239-51. (PMID: 23746840)
Nat Microbiol. 2020 Apr;5(4):536-544. (PMID: 32123347)
Sci Rep. 2019 Mar 26;9(1):5233. (PMID: 30914743)
BMC Genomics. 2008 May 16;9:225. (PMID: 18485203)
Cell. 2019 Jun 13;177(7):1888-1902.e21. (PMID: 31178118)
Nat Immunol. 2018 Mar;19(3):291-301. (PMID: 29434354)
Nature. 2021 Feb;590(7847):635-641. (PMID: 33429418)
Immunity. 2020 Sep 15;53(3):641-657.e14. (PMID: 32888418)
Nat Biotechnol. 2020 Aug;38(8):970-979. (PMID: 32591762)
Bioinformatics. 2020 Feb 1;36(3):964-965. (PMID: 31400197)
Annu Rev Immunol. 2016 May 20;34:317-34. (PMID: 27168241)
Nat Med. 2002 Jun;8(6):631-7. (PMID: 12042816)
Immunity. 2020 Dec 15;53(6):1245-1257.e5. (PMID: 33326767)
Elife. 2020 Feb 21;9:. (PMID: 32081129)
سلسلة جزيئية: figshare 10.6084/m9.figshare.12436517
المشرفين على المادة: 0 (Receptors, Antigen, T-Cell)
تواريخ الأحداث: Date Created: 20210727 Date Completed: 20210809 Latest Revision: 20240813
رمز التحديث: 20240813
مُعرف محوري في PubMed: PMC8313584
DOI: 10.1038/s41467-021-24730-4
PMID: 34312385
قاعدة البيانات: MEDLINE
الوصف
تدمد:2041-1723
DOI:10.1038/s41467-021-24730-4